The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives

L Wanka, K Iqbal, PR Schreiner - Chemical reviews, 2013 - ACS Publications
A simple, primary amine bearing a C10H15 alkyl residue was found to display potent anti-
Influenza A properties in 1964. 1 Soon thereafter, antiviral activity of this amine was found …

Pharmaceuticals that contain polycyclic hydrocarbon scaffolds

TP Stockdale, CM Williams - Chemical Society Reviews, 2015 - pubs.rsc.org
Numerous variations on structural motifs exist within pharmaceutical compounds that have
entered the clinic. These variations have amounted over many decades based on years of …

Propellanes—from a chemical curiosity to “explosive” materials and natural products

AM Dilmaç, E Spuling, A de Meijere… - Angewandte Chemie …, 2017 - Wiley Online Library
Propellanes are a unique class of compounds currently consisting of well over 10 000
representatives, all featuring two more or less inverted tetrahedral carbon atoms that are …

Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus

J Wang, Y Wu, C Ma, G Fiorin, J Wang… - Proceedings of the …, 2013 - National Acad Sciences
The influenza A virus M2 proton channel (A/M2) is the target of the antiviral drugs
amantadine and rimantadine, whose use has been discontinued due to widespread drug …

Viroporins: structure, function and potential as antiviral targets

C Scott, S Griffin - Journal of General Virology, 2015 - microbiologyresearch.org
The channel-forming activity of a family of small, hydrophobic integral membrane proteins
termed 'viroporins' is essential to the life cycles of an increasingly diverse range of RNA and …

Put a cork in it: Plugging the M2 viral ion channel to sink influenza

PH Jalily, MC Duncan, D Fedida, J Wang, I Tietjen - Antiviral research, 2020 - Elsevier
The ongoing threat of seasonal and pandemic influenza to human health requires antivirals
that can effectively supplement existing vaccination strategies. The M2 protein of influenza A …

Emerging antiviral strategies to interfere with influenza virus entry

E Vanderlinden, L Naesens - Medicinal research reviews, 2014 - Wiley Online Library
Influenza A and B viruses are highly contagious respiratory pathogens with a considerable
medical and socioeconomical burden and known pandemic potential. Current influenza …

Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus

J Wang, C Ma, J Wang, H Jo, B Canturk… - Journal of medicinal …, 2013 - ACS Publications
Anti-influenza drugs, amantadine and rimantadine, targeting the M2 channel from influenza
A virus are no longer effective because of widespread drug resistance. S31N is the …

Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant S31N mutant of the influenza A virus …

Y Wu, B Canturk, H Jo, C Ma, E Gianti… - Journal of the …, 2014 - ACS Publications
Influenza virus infections lead to numerous deaths and millions of hospitalizations each
year. One challenge facing anti-influenza drug development is the heterogeneity of the …

Heterocyclic inhibitors of viroporins in the design of antiviral compounds

VA Shiryaev, YN Klimochkin - Chemistry of heterocyclic compounds, 2020 - Springer
Ion channels of viruses (viroporins) represent a common type of protein targets for drugs.
The relative simplicity of channel architecture allows convenient computational modeling …